Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
AntidiabeticsINJECTIONGeneric

HUMALOG MIX 50/50 PEN

INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT

Standard Dose
50 UNITS/ML;50 UNITS/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview HUMALOG MIX 50/50 PEN is listed in Drugs@FDA under application 021018 (BLA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT Form and strength INJECTABLE;INJECTION - 50 UNITS/ML;50 UNITS/ML Sponsor LILLY Submission history Latest submission status date: 2023-07-21 00:00:00.

Structured Monograph

Clinical summary

Approval overview HUMALOG MIX 50/50 PEN is listed in Drugs@FDA under application 021018 (BLA). Review priority: STANDARD Marketing status: Discontinued Active ingredient INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT Form and strength INJECTABLE;INJECTION - 50 UNITS/ML;50 UNITS/ML Sponsor LILLY Submission history Latest submission status date: 2023-07-21 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.